Karamjeet Samra, NP

Karamjeet Samra practices at Premier Urgent Care of Central California in Bakersfield, California.

Karamjeet Samra's NPI, 1164001350, was assigned on April 5, 2021. Karamjeet Samra holds California license 95016611.

Karamjeet Samra's primary practice is Premier Urgent Care of Central California, at 5401 White Ln, Bakersfield, CA 93309. The practice phone is (661) 396-7100.

Karamjeet Samra's primary practice is Premier Urgent Care of Central California in Bakersfield, California. Karamjeet Samra is also affiliated with Good Samaritan Hospital. The medical group on file is Premier Valley Medical Group. Dmand AI also links Karamjeet Samra to 2 more group practices and clinics, 1 urgent care center and 1 medical group, each named with a free account. Karamjeet Samra's employer is on file too: an urgent care center.

Dmand AI tracks the electronic health record (EHR) system at each site where Karamjeet Samra practices, 5 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Karamjeet Samra's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Karamjeet Samra is licensed in California.

Dmand AI lists acute skin infection, ankle or foot injury, anxiety, asthma, chronic diabetes, chronic nasal allergies, chronic obstructive pulmonary disease (COPD) and conjunctivitis among the conditions Karamjeet Samra treats.

CMS data shows 371 Medicare services from Karamjeet Samra across 2 procedure codes in 2024, all of them office visits, for 169 Medicare patients. Medicare paid $23,910 for them. Every service was in an office.

CMS counts 169 Medicare patients who saw Karamjeet Samra in 2024. The largest group is 65 to 74, with 72 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 89% are also on Medicaid. Their average risk score is 1.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Karamjeet Samra's median patient age at 60, with 65% women.

In 2024, Karamjeet Samra wrote 1,541 Medicare Part D claims for 293 patients. 88% of them were for generic drugs. CMS names the drug for 1,176 of them, across 31 drugs with 11 or more claims each, at $43,498 in total drug cost.

Karamjeet Samra accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 8 general payments to Karamjeet Samra from 8 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Medtronic, Inc. paid the most, $34.